Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Royalty Pharma plc - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
RPRX
Nasdaq
2830
www.royaltypharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Royalty Pharma plc
Royalty Pharma, plc (RPRX) Rallied on Earnings Beat
- Jun 29th, 2026 7:16 am
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)
- Jun 15th, 2026 10:28 am
This Royalty Pharma Insider Reduced Their Stake By 10%
- Jun 12th, 2026 8:00 am
3 Unpopular Stocks We’re Skeptical Of
- Jun 12th, 2026 6:13 am
Why Is Agenus (AGEN) Down 9.6% Since Last Earnings Report?
- Jun 10th, 2026 9:30 am
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings?
- Jun 9th, 2026 8:06 am
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Jun 4th, 2026 2:15 pm
Mattel Stock Is Down 24%. Here's What a $50.9 Million Exit Could Mean
- May 29th, 2026 6:34 pm
Royalty Pharma (RPRX) Valuation Check After Strong Share Price Momentum And Royalty Growth Potential
- May 25th, 2026 5:11 pm
3 Mid-Cap Stocks We Steer Clear Of
- May 20th, 2026 4:04 am
Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance
- May 18th, 2026 6:32 am
Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions
- May 16th, 2026 3:24 am
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
- May 12th, 2026 2:15 pm
Income Investors Should Know That Royalty Pharma plc (NASDAQ:RPRX) Goes Ex-Dividend Soon
- May 11th, 2026 10:12 am
Why One Fund’s $4 Million Centerra Gold Exit Looks Like Profit-Taking Amid a 150% Rally
- May 10th, 2026 9:22 am
This Fund Cashed Out of Preformed Line Products Amid a 150% Stock Surge
- May 8th, 2026 9:14 am
10% Of This Royalty Pharma Insider's Holdings Were Sold
- May 8th, 2026 8:00 am
Royalty Pharma to present at upcoming investor conferences
- May 7th, 2026 2:15 pm
Royalty Pharma Q1 Earnings Call Highlights
- May 6th, 2026 2:42 pm
Royalty Pharma plc Q1 2026 Earnings Call Summary
- May 6th, 2026 11:07 am
Scroll